| For: | Tsang ES, Lim HJ, Renouf DJ, Davies JM, Loree JM, Gill S. Real-world treatment attrition rates in advanced esophagogastric cancer. World J Gastroenterol 2020; 26(39): 6027-6036 [PMID: 33132652 DOI: 10.3748/wjg.v26.i39.6027] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i39/6027.htm |
| Number | Citing Articles |
| 1 |
Clara Lam, Brandon Diessner, Katherine Andrade, Sydnie Stackland, Leah Park, Sandhya Mehta, Feng Lin, Winghan Jackie Kwong. Cost of disease progression among US patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. Journal of Comparative Effectiveness Research 2024; 13(5) doi: 10.57264/cer-2023-0166
|
| 2 |
Audreylie Lemelin, Martin Zarba, Kosuke Takemura, J. Connor Wells, Razane El Hajj Chehade, Frede Donskov, Camillo Porta, Guillermo De Velasco, Ian D. Davis, Lori A. Wood, Sumanta K. Pal, Aaron R. Hansen, Ben Tran, Georg A. Bjarnason, Haoran Li, Ravindran Kanesvaran, Thomas Powles, Rana R McKay, Toni K. Choueiri, Daniel Y.C. Heng. Attrition rates in metastatic renal cell carcinoma (mRCC) following first line immunotherapy-based treatment: results from the International mRCC Database Consortium (IMDC). Clinical Genitourinary Cancer 2025; : 102484 doi: 10.1016/j.clgc.2025.102484
|
| 3 |
Jenny Shand, Elizabeth Stovold, Lucy Goulding, Kate Cheema. Cancer care treatment attrition in adults: Measurement approaches and inequities in patient dropout rates – a rapid review. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13096-7
|
